Investor alert: law offices of howard g. smith continues investigation of regeneron pharmaceuticals, inc. (regn) on behalf of investors

Bensalem, pa.--(business wire)--law offices of howard g. smith continues its investigation on behalf of regeneron pharmaceuticals, inc. (“regeneron” or the “company”) (nasdaq: regn) investors concerning the company's possible violations of federal securities laws. on april 10, 2024, the us department of justice (“doj”) announced the united states had filed a complaint against regeneron under the false claims act. that announcement stated the complaint “alleges that regeneron fraudulently inflat.
REGN Ratings Summary
REGN Quant Ranking